Cara Therapeutics Inc (OQ:CARA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CARA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 22/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -371 $16.00
May 22/20 May 21/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -3,500 $16.00
May 22/20 May 20/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -1,200 $16.00
May 14/20 May 12/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -4,929 $16.00
May 14/20 May 12/20 Ives Jeffrey L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
May 14/20 May 12/20 Ives Jeffrey L. Direct Ownership Common Stock S - Open market or private sale -2,500 $16.00
May 14/20 May 12/20 Ives Jeffrey L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $9.94
Apr 21/20 Apr 21/20 Ives Jeffrey L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Apr 21/20 Apr 21/20 Ives Jeffrey L. Direct Ownership Common Stock S - Open market or private sale -2,500 $16.00
Apr 21/20 Apr 21/20 Ives Jeffrey L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $9.94
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CARA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 22/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -371 $16.00
May 22/20 May 21/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -3,500 $16.00
May 22/20 May 20/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -1,200 $16.00
May 14/20 May 12/20 Chalmers Derek T Direct Ownership Common Stock S - Open market or private sale -4,929 $16.00
May 14/20 May 12/20 Ives Jeffrey L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
May 14/20 May 12/20 Ives Jeffrey L. Direct Ownership Common Stock S - Open market or private sale -2,500 $16.00
May 14/20 May 12/20 Ives Jeffrey L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $9.94
Apr 21/20 Apr 21/20 Ives Jeffrey L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Apr 21/20 Apr 21/20 Ives Jeffrey L. Direct Ownership Common Stock S - Open market or private sale -2,500 $16.00
Apr 21/20 Apr 21/20 Ives Jeffrey L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $9.94
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CARA

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)